Skip to main content

Henry Schein, Inc. (HSIC) Stock Analysis

SellVALUE-TRAP 1/5Moderate Confidence

Healthcare · Medical Distribution

Earnings in 4 days (2026-05-05). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Sell if holding. At $74.13, A.R:R 1.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 5.9%; Earnings in 4 days (event risk).

Henry Schein distributes dental and medical products to over 1 million customers worldwide through Global Distribution/Value-Added Services (84.5% of 2025 revenue), Global Specialty Products (11.7%), and Global Technology (5.1%) segments. Operations span 34 countries with... Read more

$74.13+5.9% A.UpsideScore 4.9/10#4 of 5 Medical Distribution
Stop $70.60Target $78.49(analyst − 13%)A.R:R 1.2:1
Analyst target$90.21+21.7%14 analysts
$78.49our TP
$74.13price
$90.21mean
$64
$104

Sell if holding. At $74.13, A.R:R 1.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 5.9%; Earnings in 4 days (event risk). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Score 4.9/10, moderate confidence.

Passes 4/7 gates (clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and earnings proximity 4d<=7d. Suitability: moderate.

Thesis

Rewards
Earnings estimates trending UP
Risks
Thin upside margin: 5.9%
Earnings in 4 days (event risk)
Consecutive earnings misses (3)

Key Metrics

P/E (TTM)22.8
P/E (Fwd)12.7
Mkt Cap$8.6B
EV/EBITDA13.1
Profit Mgn3.0%
ROE8.7%
Rev Growth7.7%
Beta0.88
DividendNone
Rating analysts22

Quality Signals

Piotroski F8/9

Options Flow

P/C0.73neutral
IV53%elevated
Max Pain$50-32.6% vs spot

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

2 floor-breakers

Momentum below the gate floor. Component breakdown shows what dragged the score down.static

Macd
0.0
Obv
1.0
Volume
1.6
Ma Position
4.0
Rsi
5.5
Volume distribution (falling OBV)Above 200-day MA

No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static

Earnings History
0.0
Surprise Avg
0.0
Earnings Timing
5.0
Erm
6.5
Earnings concerns: 1B/3MEarnings in 4 days
GatesMomentum 2.4<4.5A.R:R 1.2 < 1.5@spotEARNINGS PROXIMITY 4d<=7dInsider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARSuitability: Moderate
RSI
41 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $72.78Resistance $81.10

Price Targets

$71
$78
A.Upside+5.9%
A.R:R1.2:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeCautious

Risk Alerts

! Momentum score 2.4/10 — below 4.5 minimum
! Reward/Risk 1.2:1 at current price — below 1.5:1 minimum
! EARNINGS_PROXIMITY:4d<=7d

Earnings

B
M
M
M
1/4 beats
Next Earnings2026-05-05 (4d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is HSIC stock a buy right now?

Sell if holding. At $74.13, A.R:R 1.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 5.9%; Earnings in 4 days (event risk). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Prior stop was $70.60. Score 4.9/10, moderate confidence.

What is the HSIC stock price target?

Take-profit target: $78.49 (+5.9% upside). Prior stop was $70.60. Stop-loss: $70.60.

What are the risks of investing in HSIC?

Thin upside margin: 5.9%; Earnings in 4 days (event risk); Consecutive earnings misses (3).

Is HSIC overvalued or undervalued?

Henry Schein, Inc. trades at a P/E of 22.8 (forward 12.7). TrendMatrix value score: 6.6/10. Verdict: Sell.

What do analysts say about HSIC?

22 analysts cover HSIC with a consensus score of 3.8/5. Average price target: $90.

What does Henry Schein, Inc. do?Henry Schein distributes dental and medical products to over 1 million customers worldwide through Global...

Henry Schein distributes dental and medical products to over 1 million customers worldwide through Global Distribution/Value-Added Services (84.5% of 2025 revenue), Global Specialty Products (11.7%), and Global Technology (5.1%) segments. Operations span 34 countries with 25,000+ employees.

Related stocks: CAH (Cardinal Health, Inc.) · COR (Cencora, Inc.) · AHG (Akso Health Group) · INCY (Incyte Corporation) · HRMY (Harmony Biosciences Holdings, I)